Particularly, the role of synergies in pathological processes reflected by biomarkers for amyloid-beta (‘A’), tau (‘T’), and neurodegeneration (‘N’) in progression along the AD continuum is not fully understood. This evidence concerns the gene MAPT and Alzheimer disease.